Navigation Links
BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
Date:6/23/2009

This next-generation BD Viper System with XTR technology enables laboratories to process a higher volume of tests automatically from swabs or urine samples, with significantly less labour and more reliable test results. This improvement in process efficiency may lead to a higher number of accurate diagnoses and more appropriate patient care for the two most common sexually transmitted infections - Chlamydia and gonorrhea. If left untreated, these infections in women can lead to pelvic inflammatory disease, infertility, ectopic pregnancy and chronic pelvic pain.

Oxford, UK (PRWeb UK) June 23, 2009 -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company ), recently announced the CE marking of the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay for use on the BD Viper™ System with XTR™ Technology.

This next-generation BD Viper System with XTR technology enables laboratories to process a higher volume of tests automatically from swabs or urine samples, with significantly less labour and more reliable test results. This improvement in process efficiency may lead to a higher number of accurate diagnoses and more appropriate patient care for the two most common sexually transmitted infections - Chlamydia and gonorrhea. If left untreated, these infections in women can lead to pelvic inflammatory disease, infertility, ectopic pregnancy and chronic pelvic pain.

"BD ProbeTec Qx Amplified DNA Assays are designed to meet the needs of today's high-volume clinical laboratories, providing extremely reliable detection of Chlamydia trachomatis and Neisseria gonorrhoeae," said Jonathan Barrett, Business Director, UK and Ireland, BD Diagnostics - Diagnostic Systems. "Running these advanced molecular assays on the BD Viper System with advanced XTR technology offers labor
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
(Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 ... discuss federal testosterone lawsuits that have been filed by ... for the second week in March, the Firm notes. ... Court’s website, parties involved in the federal litigation will ... address matters related to prescription therapy treatments designed to ...
(Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
(Date:2/28/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlay Chromatic Grunge 6K ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlay Chromatic was professionally designed to add level of ... Overlay Chromatic Grunge 6K is a resourceful tool from Pixel ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2
... Inc. announced today an initiation of Phase I clinical ... of Alzheimer,s disease. The results of Phase I studies ... on these and other results, Avineuro Pharmaceuticals, Inc. plans ... Q2 2009. Avineuro Pharmaceuticals, Inc. presented at the 9th ...
... Show U.S. Rx Abandonment Rate Up 34 Percent Since ... 2008BRIDGEWATER, N.J., April 7 /PRNewswire/ ... of information and business intelligence for students, professionals and ... pharmaceutical industry, today released its annual analysis of the ...
... services , ... Dallas, TX (Vocus) April 7, 2009 ... Blue Island, Illinois has selected Broadlane as the exclusive provider of ... approximate $25 million in annual spend., , , , ,MetroSouth Medical ...
... to compliment the Small Business Administration,s recent announcement of $730 million ... banks and make it easier for entrepreneurs and start-ups to get ... ... (PRWEB) April 7, 2009 -- Health Career Agents announces SBA Pre-Approval ...
... vital for charities - Charity websites help raise ... networks - Women in Need helps women from ... illness, rape & abuseHARTFORD, England, April 7 ... from Hartford, Cheshire, has recently completed a newly ...
... Intervet/Schering-Plough Animal Health today announces that the ... testing goes to Dr. Ivo Claassen for a ... Veterinary Institute (CVI), Lelystad (the Netherlands). The announcement ... an independent expert jury panel and Professor of ...
Cached Medicine News:Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 2Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 3Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 4Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 2Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 3Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 4Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:Local Web Design Agency Launches Leprosy Charity Website for Women in Need 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 3
(Date:2/27/2015)... Feb. 27, 2015 Pharmaceutical and biotech marketers ... products for the same indication. This can be a ... to prevent one of their brands from gaining market ... to recent research by benchmarking firm, Best Practices, LLC, ... brands rather than together as part of a franchise. ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... published in the Proceedings of the National ... showed when ibrutinib (IMBRUVICA ® ) was combined ... of tumor growth was enhanced suggesting a greater ... cancers and solid tumors with the combination. IMBRUVICA ...
(Date:2/27/2015)... Feb. 27, 2015 Securities lawyers at ... Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in ... Concerned SLXP investors are encouraged to contact attorney Hamilton ... The investigation focuses upon the shareholder value of the ... would receive only $158.00 per share in cash. At ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9
... BIRMINGHAM, Ala. , Feb. 4 BioCryst Pharmaceuticals, ... the fourth quarter and year ended December 31, 2009 ... strides towards the goal of building an enduring and successful ... Chief Executive Officer of BioCryst Pharmaceuticals.  "Peramivir has delivered the ...
... REDWOOD CITY, Calif. , Feb. 3 Genomic Health, ... ended December 31, 2009 , which included 35 percent revenue growth ... revenue for the fourth quarter of 2009 increased to $39.6 million ... 2008.  Product revenue from the Onco type DX® breast cancer test ...
Cached Medicine Technology:BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 2BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 3BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 4BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 5BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 6BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 7BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 8BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 9BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 10Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
... SBI RingFix is a modular external fixation ... large variety of clinical needs. Originally marketed ... has a successful 20 year history of ... Developed around the principles of the Ilizarov ...
... QuickLink™ Delivery System is ... designed to assemble brachytherapy ... Connectors into seed trains ... with variable seed to ...
... ImmunoCard STAT! EHEC is the first one-step 20 ... Toxin 1 and 2 produced by Enterohemorrhagic Escherichia ... McConkey broth overnight enrichment of fecal specimens and ... 100% specificity., The separate result for Toxin 1 ...
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
Medicine Products: